Skip to content

Faculty profile

Karl Fernandes

Back to faculty
ResearcherMédecineUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Electrocorticographic, astrocytic and transcriptomic signatures in the triple transgenic mouse model of Alzheimer's disease submitted to stearoyl-CoA desaturase inhibition.

    Neuropharmacology · 2026

  • Cerebrospinal fluid CEFA composition is enriched in saturated fatty acids and it is altered in Alzheimer's disease.

    Journal of lipid research · 2026

All 2 publications

Latest funding

  • The hypothalamus in aging and Alzheimer's disease

    CIHR · 2026 · Nominated PI

    $1,315,800
  • Novel treatment of Alzheimer's disease by early targeting and visualizing soluble amyloid beta oligomers using cyclic azapeptides

    CIHR · 2025 · Co-investigator

    $1,086,300
  • Decoding and challenging choroid plexus inflammation in the aging brain

    CIHR · 2024 · Co-investigator

    $1,071,000
All 9 grants and awards
Something wrong or missing on this profile? Suggest a correction